Even if a person survives a heart attack, its effects set the stage for future trauma. Rohan Dharmakumar outlines those risks—discoveries that could allow the Krannert Cardiovascular Research
Institute to limit damage and prevent tragedy.
When Violet Refbord was born, glaucoma threatened to steal her vision. Her parents turned to pediatric ophthalmologists at Indiana University School of Medicine, where the latest advances in training and research have saved eyesight for five decades.
Over the last 25 years, hundreds of clinical trials for drugs treating Alzheimer’s disease have failed. As the field takes stock, a team at IU School of Medicine hunts for new targets—and hope for patients.